Should Fallopian Tubes Be Removed During Hysterectomy Procedures? – A Statement by AGO Ovar

Por Pölcher, M., Hauptmann, S., Fotopoulou, C., Schmalfeldt, B., Meinhold-Heerlein, I., Mustea, A., Runnebaum, I., Sehouli, J.
Publicado no Geburtshilfe Frauenheilkd (2015)

Statement by the Kommission Ovar of the AGO: The New FIGO and WHO Classifications of Ovarian, Fallopian Tube and Primary Peritoneal Cancer

Por Meinhold-Heerlein, I., Fotopoulou, C., Harter, P., Kurzeder, C., Mustea, A., Wimberger, P., Hauptmann, S., Sehouli, J.
Publicado no Geburtshilfe Frauenheilkd (2015)

Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab – a translational project in the neoadjuvant GeparQuinto trial

Por Witzel, I, Loibl, S, von Minckwitz, G, Eidtmann, H, Fehm, T, Khandan, F, Schmatloch, S, Hauschild, M, Bischoff, J, Fasching, P A, Mau, C, Schem, C, Rack, B, Meinhold-Heerlein, I, Liedtke, C, Karn, T, Huober, J, zu Eulenburg, C, Issa-Nummer, Y, Untch, M, Müller, V
Publicado em 2012